Dr Janet Bastiman discusses the future of AI for AML and offers expert guidance on how best to collaborate with the FCA and ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DataVisor, a stand-out provider of AI-powered fraud and financial crime prevention solutions, has been recognized as a Leader, the report’s highest designation, ...
Financial institutions need to remain vigilant about managing anti-money laundering and Bank Secrecy Act (AML/BSA) compliance in 2025. As the financial ecosystem becomes increasingly complex, and as ...
SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
Academic-community partnerships can reduce patient travel burdens while maintaining high-quality cancer care, as demonstrated by successful high-dose cytarabine consolidation delivery. A flow ...
Sellas Life Sciences has surged over 250% since December 2025, driven by positive clinical data for its AML therapies. Learn ...
SLS and ATNM are heading into the AACR summit with fresh leukemia-focused data catalysts expected to refocus investor attention. ・Sellas will present preclinical AML data on SLS009, demonstrating ...
AML Best Practices for Private Fund Managers: The Prudence of Establishing an AML Compliance Program
Notwithstanding the foregoing, as a good business practice and to align with industry standards, Advisers are increasingly implementing for themselves and their Private Funds limited anti-money ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results